Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Prog Nucl Magn Reson Spectrosc. 2011 Apr 23;59(4):319–335. doi: 10.1016/j.pnmrs.2011.04.002

Fig. 4.

Fig. 4

Schematic diagram showing the multiple in vivo 17O measurements at 9.4T for determining CMRO2 using the complete model according to the mass balance equation of Eq. [7] which links Cb(t), Ca(t), CBF and n with CMRO2. To simplify the equation, three known constants of 2αf1, mf2 and m/λ used in Eq. [7] are replaced by k1, k2 and k3, respectively. (A) Stacked plot of the 17O spectra of cerebral H217O tracer from one representative voxel as indicated by the circle in the anatomical brain image (low center insert). The spectra were acquired before and after a bolus injection of H217O for CBF measurements. (B) Stacked plot of the 17O spectra of the metabolic H217O from the same voxel acquired before (natural abundance), during (as indicated by the gray bar under the stacked plot) and after a 2-minute 17O2 inhalation. (C) Measurement of Ca(t) by using an implanted 17O RF coil (the left insert). The middle insert illustrates an 17O spectrum of natural abundance H217O obtained from the rat carotid artery blood with the implanted coil before 17O2 inhalation. The right insert shows the time course of Ca(t) (circle symbol) and Cb(t) from a representative 3D 17O CSI voxel (square symbol) in the same rat during the 17O2 inhalation. Finally, the ratio between the 17O signal decay detected after a bolus injection of H217O (see Fig. 4A) versus the 17O signal decay detected after the cessation of 17O2 inhalation (see Fig. 4B) gives the constant of n. Adapted from Zhu et. al. PNAS 2002; 99: 13194–13199.